Clinical Trial Update: Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease [NA]

View source ↗

Summary

Sponsored by R3 Vascular, the trial evaluates a bioresorbable sirolimus-eluting scaffold for below-the-knee disease in chronic limb-threatening ischemia and is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb-threatening Ischemia

Drugs mentioned

• Bioresorbable Sirolimus-eluting scaffold (sirolimus-eluting scaffold)

Snippet

Sponsor: R3 Vascular Inc. | Conditions: Chronic Limb-Threatening Ischemia | NA | Status: RECRUITING